E. Derom (Gent, Belgium), J. Lammers (Utrecht, The Netherlands)
Electrohydrodynamic atomization of drug solutions for inhalation purposes
P. Zanen, K. Geerse, J. C. M. Marijnissen, J. W. J. Lammers (Utrecht, Delft, The Netherlands)
|  |
Particle size and gravimetric characteristics of Clenny Aerosol, a new jet nebulizer with breath enhanced bulb
C. Terzano, G. Cremonesi, I. Panza (Parma, Italy)
| |
Optimal inhalation profiles, effect of instruction and correlation with lungfunction
M. Broeders, J. Molema, H. Folgering (Groesbeek, The Netherlands)
| |
Peak inspiratory flow (PIF) when using a dry powder inhaler in asthmatics and COPD
G. J. Huchon, J. F. Dessanges, I. Pin, J. M. Aiache, J. Barthe, J. G. Perilliat (Paris, France)
| |
Selection of the dry powder inhaler based on peak inspiratory measurements in the preselected group of patients with bronchial obstruction
A. Emeryk, M. Emeryk, M. Kokot (Warszawa, Lublin, Warsaw, Poland)
| |
Three modes of delivery of steroids in asthma: a comparison
S. H. Kini, K. Jain, S. T. Nabar, S. Drago, S. Pednekar, P. Panchal, V. Iyengar, A. J. Pai-Dhungat (Mumbai, India)
| |
Bronchodilatation and systemic β2-response measurement in asthmatic patients after using salbutamol comparing a metal and a plastic spacer
R. Janssen, M. Weda, J. W. J. Lammers, P. Zanen (Utrecht, Bilthoven, The Netherlands)
| |
Equivalence testing of salbutamol dry powder inhalers by in vitro impaction
M. Weda, P. Zanen, A. de Boer, D. M. Barends, H. W. Frijlink (Bilthoven, Nieuwegein, Groningen, The Netherlands)
| |
The importance of proper instruction for use and maintenance of Nebuchambers
A. Barak, O. Efrati, Y. Lotem, N. Elias, I. Amirav (Ramat Gan, Ramla, Haifa, Zafed, Israel)
| |
Comparison of two budesonide powder inhalers, Giona Easyhaler® and Pulmicort Turbuhaler® in steroid-naive asthmatic patients
H. Schweisfurth, A. Malinen, T. Koskela, P. Toivanen, M. Ranki-Pesonen (Berlin, Germany; Kuopio, Finland)
| |
Budesonide 800 μg/day via Easyhaler® is as safe and effective as the same dose of budesonide via Turbuhaler® in adult asthmatics
H. Tukiainen on Behalf of the Study Group, K. M. Hämäläinen, J. Keski-Karhu (Kuopio, Finland)
| |
Budesonide (800 and 1600 μg/day) via Easyhaler® has equivalent systemic activity to the same doses via Turbuhaler®
K. M. Hämäläinen, A. Malinen, M. Granander, P. Toivanen (Kuopio, Finland)
| |
Aerosol characterization of three corticosteroids in MDIs plus a new spacer device (Fluspacer®) vs MDIs alone
C. Terzano (Italy)
| |
Assessment on the efficiency of Clenny Aerosol, a new jet nebulizer with breath-enhanced bulb
C. Terzano, G. Cremonesi, I. Panza (Parma, Italy)
| |
A multicentre, double-blind, double-dummy, randomized, parallel group study to assess efficacy and safety of beclomethasone dipropionate and ease of handling of a breath operated aerosol inhaler in adults with reversible airways obstruction
B. Novotná, J. Teturová, P. Kolman, J. Hlavatý, L. Pavelková, D. Svoboda, A. C. Berggren (Brno, Breclav, Kyjov, Liberec, Olomouc, Hradec Králové, Prague, Czech Republic)
| |
Bronchodilator response to salbutamol administered through metered-dose inhaler plus spacer or dry-powder inhaler in asthmatic patients
F. Lavorini, G. A. Fontana, G. Camiciottoli, W. Castellani, N. M. Maluccio, M. Pistolesi (Florence, Italy)
| |
Effect of fine particle mass (FPM) on the bronchodilator and bronchoprotective properties of salmeterol
S. J. Langley, B. McDonnell, D. Allen, N. Wheeler, M. Briggs, A. A. Woodcock (Manchester, Uxbridge, United Kingdom)
| |
In vitro testing of two budesonide dry powder inhalers at different flow rates
T. Weuthen, C. Herpich, R. von Kracht, T. Meyer, G. Scheuch (Gauting, Germany)
| |
Characterization of airflow properties of the mometasone furoate dry powder inhaler
D. Kenyon (Union, United States Of America)
| |
Effect of the actuator orifice diameter on the biodisposition of a new budesonide CFC-free metered dose inhaler formulation
G. Poli, D. Acerbi, A. Simonon, A. Knops (Parma, Italy; Wavre, Antwerpen, Belgium)
| |